{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T22:57:46Z","timestamp":1700002666822},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T00:00:00Z","timestamp":1232496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s12185-008-0244-7","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T00:04:34Z","timestamp":1232409874000},"page":"218-222","source":"Crossref","is-referenced-by-count":7,"title":["Immunoglobulin M \u2018Flare\u2019 after rituximab-associated acute tubular necrosis in Waldenstr\u00f6m\u2019s macroglobulinemia"],"prefix":"10.1007","volume":"89","author":[{"given":"Hassane","family":"Izzedine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Bourry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucile","family":"Amrouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Brocheriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalina","family":"Uzunov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederique","family":"Capron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Leblond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert","family":"Deray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,21]]},"reference":[{"key":"244_CR1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S1470-2045(03)01246-4","volume":"4","author":"IM Ghobrial","year":"2003","unstructured":"Ghobrial IM, Gertz MA, Fonseca R. Waldenstr\u00f6m macroglobulinaemia. Lancet Oncol. 2003;4:679\u201385. doi: 10.1016\/S1470-2045(03)01246-4 .","journal-title":"Lancet Oncol"},{"key":"244_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/sonc.2003.50082","volume":"30","author":"RG Owen","year":"2003","unstructured":"Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom\u2019s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom\u2019s Macroglobulinemia. Semin Oncol. 2003;30:110\u20135.","journal-title":"Semin Oncol"},{"key":"244_CR3","first-page":"631","volume":"9","author":"N Burwick","year":"2008","unstructured":"Burwick N, Roccaro AM, Leleu X, Ghobrial IM. Targeted therapies in Waldenstr\u00f6m macroglobulinemia. Curr Opin Investig Drugs. 2008;9:631\u20137.","journal-title":"Curr Opin Investig Drugs"},{"key":"244_CR4","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1200\/JCO.2005.03.144","volume":"23","author":"MA Dimopoulos","year":"2005","unstructured":"Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP. Diagnosis and management of Waldenstrom\u2019s macroglobulinemia. J Clin Oncol. 2005;23:1564\u201377. doi: 10.1200\/JCO.2005.03.144 .","journal-title":"J Clin Oncol"},{"key":"244_CR5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1159\/000064299","volume":"91","author":"J Isaac","year":"2002","unstructured":"Isaac J, Herrera GA. Cast nephropathy in a case of Waldenstr\u00f6m\u2019s macroglobulinemia. Nephron. 2002;91:512\u20135. doi: 10.1159\/000064299 .","journal-title":"Nephron"},{"key":"244_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/00041552-199503000-00005","volume":"4","author":"PM Ronco","year":"1995","unstructured":"Ronco PM, Mougenot B, Touchard G, et al. Renal involvement in hematological disorders: monoclonal immunoglobulins and nephropathy. Curr Opin Nephrol Hypertens. 1995;4:130\u20138. doi: 10.1097\/00041552-199503000-00005 .","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"244_CR7","doi-asserted-by":"publisher","unstructured":"Gertz MA, Merlini G, Treon SP. Amyloidosis and Waldenstr\u00f6m\u2019s macroglobulinemia. Hematology Am Soc Hematol Educ Program. 2004;257\u201382. doi: 10.1182\/asheducation-2004.1.257 .","DOI":"10.1182\/asheducation-2004.1.257"},{"key":"244_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1053\/sonc.2003.50054","volume":"30","author":"M Bj\u00f6rkholm","year":"2003","unstructured":"Bj\u00f6rkholm M, Johansson E, Papamichael D, et al. Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom\u2019s macroglobulinemia: a two-institution study. Semin Oncol. 2003;30:226\u201330. doi: 10.1053\/sonc.2003.50054 .","journal-title":"Semin Oncol"},{"key":"244_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1053\/sonc.2003.50038","volume":"30","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Treon SP, Alexanian R, et al. Prognostic markers and criteria to initiate therapy in Waldenstrom\u2019s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom\u2019s Macroglobulinemia. Semin Oncol. 2003;30:116\u201320.","journal-title":"Semin Oncol"},{"key":"244_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0025-6196(12)65225-2","volume":"62","author":"RA Kyle","year":"1987","unstructured":"Kyle RA, Garton JP. The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc. 1987;62:719\u201331.","journal-title":"Mayo Clin Proc"},{"key":"244_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJM197007162830304","volume":"283","author":"L Morel-Maroger","year":"1970","unstructured":"Morel-Maroger L, Basch A, Danon F, et al. Pathology of the kidney in Waldenstr\u00f6m\u2019s macroglobulinemia. Study of sixteen cases. N Engl J Med. 1970;283:123\u20139.","journal-title":"N Engl J Med"},{"key":"244_CR12","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1001\/archinte.1977.03630230085023","volume":"137","author":"ME Grossman","year":"1977","unstructured":"Grossman ME, Bia MJ, Goldwein MI, et al. Giant kidneys in Waldenstr\u00f6m\u2019s macroglobulinemia. Arch Intern Med. 1977;137:1613\u20135. doi: 10.1001\/archinte.137.11.1613 .","journal-title":"Arch Intern Med"},{"key":"244_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3109\/10428199509056840","volume":"17","author":"DF Moore Jr","year":"1995","unstructured":"Moore DF Jr, Moulopoulos LA, Dimopoulos MA. Waldenstr\u00f6m macroglobulinemia presenting as a renal or perirenal mass: clinical and radiographic features. Leuk Lymphoma. 1995;17:331\u20134. doi: 10.3109\/10428199509056840 .","journal-title":"Leuk Lymphoma"},{"key":"244_CR14","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2214\/ajr.138.6.1101","volume":"138","author":"SZ Jafri","year":"1982","unstructured":"Jafri SZ, Bree RL, Amendola MA, et al. CT of renal and perirenal non-Hodgkin lymphoma. AJR Am J Roentgenol. 1982;138:1101\u20135.","journal-title":"AJR Am J Roentgenol"},{"key":"244_CR15","first-page":"196","volume":"41","author":"FD Lindstr\u00f6m","year":"1980","unstructured":"Lindstr\u00f6m FD, Hed J, Enestr\u00f6m S. Renal pathology of Waldenstr\u00f6m\u2019s macroglobulinaemia with monoclonal antiglomerular antibodies and nephrotic syndrome. Clin Exp Immunol. 1980;41:196\u2013204.","journal-title":"Clin Exp Immunol"},{"key":"244_CR16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/archinte.1985.00360050199038","volume":"145","author":"J Matsumoto","year":"1985","unstructured":"Matsumoto J, Yasaka T, Ohya I, Ohtani H. Acute renal failure in primary macroglobulinemia with small-molecule IgM. Arch Intern Med. 1985;145:929\u201331. doi: 10.1001\/archinte.145.5.929 .","journal-title":"Arch Intern Med"},{"issue":"4","key":"244_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s10157-008-0042-9","volume":"12","author":"A Shaikh","year":"2008","unstructured":"Shaikh A, Habermann TM, Fidler ME, et al. Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenstr\u00f6m\u2019s macroglobulinemia. Clin Exp Nephrol. 2008;12(4):292\u20135.","journal-title":"Clin Exp Nephrol"},{"key":"244_CR18","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1152\/ajplegacy.1976.230.5.1448","volume":"230","author":"KM McDonald","year":"1976","unstructured":"McDonald KM. Influence of blood rheology on intrarenal blood flow distribution. Am J Physiol. 1976;230:1448\u201354.","journal-title":"Am J Physiol"},{"key":"244_CR19","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1002\/cncr.20658","volume":"101","author":"IM Ghobrial","year":"2004","unstructured":"Ghobrial IM, Fonseca R, Greipp PR, et al. Eastern Cooperative Oncology Group. Initial immunoglobulin M \u2018flare\u2019 after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study. Cancer. 2004;101:2593\u20138. doi: 10.1002\/cncr.20658 .","journal-title":"Cancer"},{"key":"244_CR20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/annonc\/mdh403","volume":"15","author":"SP Treon","year":"2004","unstructured":"Treon SP, Branagan AR, Hunter Z, et al. Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom\u2019s macroglobulinemia. Ann Oncol. 2004;15:1481\u20133. doi: 10.1093\/annonc\/mdh403 .","journal-title":"Ann Oncol"},{"key":"244_CR21","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1200\/JCO.2005.04.6474","volume":"24","author":"V Noronha","year":"2006","unstructured":"Noronha V, Fynan TM, Duffy T. Flare in neuropathy following rituximab therapy for Waldenstrom\u2019s macroglobulinemia. J Clin Oncol. 2006;24:e3. doi: 10.1200\/JCO.2005.04.6474 .","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0244-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-008-0244-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0244-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0244-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:01:23Z","timestamp":1559437283000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-008-0244-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,21]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["244"],"URL":"https:\/\/doi.org\/10.1007\/s12185-008-0244-7","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,21]]}}}